Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06643351 · ClinicalTrials.gov registry record · NA

Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia

A NA study of Gestational Diabetes Mellitus in Pregnancy and Neonatal Hypoglycemia, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
218
Enrollment target
1
Study location

NCT06643351 is a NA study of Gestational Diabetes Mellitus in Pregnancy and Neonatal Hypoglycemia that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 218 participants, below the 1,852-participant average among 9 other Gestational Diabetes Mellitus in Pregnancy trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06643351, a NA study of Gestational Diabetes Mellitus in Pregnancy and Neonatal Hypoglycemia, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
218 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess whether a liberal intrapartum glycemic target range compared to usual care standard control ranges will lead to a decrease in the rate of neonatal hypoglycemia among pregnant patients in labor with diabetes.

Interventions

  • OTHER Standard Intrapartum Glucose Target Range
  • OTHER Liberalized Intrapartum Glucose Target Range

Study Locations (1)

Pennsylvania

  • Magee-Women's Hospital of UPMC - Pittsburgh

Trial Details

FieldValue
Enrollment Target 218 participants
Start Date 2024-12-03
Est. Completion 2026-06
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT06643351

The ClinicalTrials.gov registry entry for NCT06643351 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 218 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,852-participant average among 9 other Gestational Diabetes Mellitus in Pregnancy trials with a reported enrollment target (88% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Gestational Diabetes Mellitus in Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Standard Intrapartum Glucose Target Range is the first listed.

NCT06643351 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06643351 about?

NCT06643351 is a clinical study titled "Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia". The purpose of this study is to assess whether a liberal intrapartum glycemic target range compared to usual care standard control ranges will lead to a decrease in the rate of neonatal hypoglycemia among pregnant patients in labor with diabetes.

What is the current status of trial NCT06643351?

This trial is currently recruiting. It is a NA study. The enrollment target is 218 participants. The study started on 2024-12-03. Estimated completion is 2026-06.

What conditions does trial NCT06643351 study?

This clinical trial studies the following conditions: Gestational Diabetes Mellitus in Pregnancy, Neonatal Hypoglycemia, Pregestational Diabetes Mellitus.

What interventions are being tested in trial NCT06643351?

The interventions under investigation include: Standard Intrapartum Glucose Target Range (OTHER), Liberalized Intrapartum Glucose Target Range (OTHER).

Who is sponsoring clinical trial NCT06643351?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06643351 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gestational Diabetes Mellitus in Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.